![]() ![]() Sanofi Genzyme developed Isatuximab (SAR 650984) which is another anti-CD38 antibody that has shown single-agent activity in Phase I testing among heavily pre-treated myeloma patients. The reason the term rescue can be used to describe an autologous stem cell transplant, is because when a lymphoma is not responding to treatment, or continually coming back after treatment stronger measures are needed to. ![]() Follow Sanofi Genzyme on Twitter #myeloma awareness initiative continues to BUILD a bridge for raising funds! In an autologous stem cell transplant, the transplanted cells are the patient’s own cells being reinfused back into them. So please start Tweeting and be sure to include the hashtags #IMambo4Myeloma and #BMTTandem16 in each of your tweets and RTs. Sanofi Genzyme will make a $10.00 donation to CIBMTR and ASBMT for every 10 Tweets and Retweets which include the Hashtags #IMambo4Myeloma and #BMTTandem16, starting NOW through February 23rd. All the cells in your body start as stem cells. ![]() The transplanted cells help support your body to produce healthy stem cells. The most common indication for autologous stem cell transplantation in the United States is multiple myeloma, and this article is designed to provide the specifics of organizing a transplant program for multiple myeloma. In 1981, UCSF's Gail Martin co-discovered embryonic stem cells in mice and coined the term 'embryonic stem cell.' Today, our stem cell center is one of the largest in the U.S., and our researchers there are developing new treatment strategies for a broad range of disorders, including heart disease, diabetes, neurological conditions and cancer. What is an autologous stem cell transplant Auto means self, so this procedure uses your own stem cells to replace stem cells that are damaged by high-dose chemotherapy. To help raise #MultipleMyeloma awareness among bone and marrow transplant specialist members of the Center for International Bone & Marrow Transplant Research (CIBMTR) and the American Society of Blood & Marrow Transplant (ASBMT), Sanofi Genzyme will raise recognition for the Multiple Myeloma Community at the upcoming #BMTTandem16 Annual Meeting in Ho nolulu, Hawaii, February 18th through February 22nd. The rate of new myeloma cases has been rising 0.7 per year during the past decade. #IMamboforMyeloma is going to #BMTTandem16 ! ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |